AP NEWS

Post Menopausal Osteoporosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019 - ResearchAndMarkets.com

January 22, 2019

DUBLIN--(BUSINESS WIRE)--Jan 22, 2019--The “Post Menopausal Osteoporosis - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering.

This report provides comprehensive insights about marketed and Phase III products for Post Menopausal Osteoporosis. The report includes information of marketed products including their product description, patent details, forecasted sales till 2021 & API manufacturer details by country.

Global API Manufacturers of Marketed Products for Post Menopausal Osteoporosis

Coverage of API manufacturers for Post Menopausal Osteoporosis marketed products spanning across United States, Europe, China and India. The manufacturers’ details include manufacturers’ name along with their location.

Emerging Phase III products for Post Menopausal Osteoporosis

This report provides a comprehensive understanding of the emerging Phase III therapies for Post Menopausal Osteoporosis which can turn out to be future prospective competitors for the marketed products. It will also put light on the current market trends. Their forecasted global sales are also provided till 2021.

Topics Covered

1. Report Introduction

2. Post Menopausal Osteoporosis - Overview

3. Comparative Analysis of Marketed & Emerging Products

4. Marketed Therapies

5. Emerging Therapies (Phase III)

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/dnx9z9/post_menopausal?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190122005424/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Women’s Health,Endocrine and Metabolic Disorders Drugs,Musculoskeletal Disorders Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH GENERAL HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 01/22/2019 05:35 AM/DISC: 01/22/2019 05:35 AM

http://www.businesswire.com/news/home/20190122005424/en

AP RADIO
Update hourly